Old Web
English
Sign In
Acemap
>
authorDetail
>
Wilfried J. Graveland
Wilfried J. Graveland
Erasmus University Medical Center
Pathology
Medicine
Oligodendroglioma
Vincristine
Immunology
4
Papers
576
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
2006
European Journal of Cancer
Mathilde C.M. Kouwenhoven
Johan M. Kros
Pim J. French
Elize M. Biemond-ter Stege
Wilfried J. Graveland
Martin J.B. Taphoorn
Alba A. Brandes
Martin J. van den Bent
Show All
Source
Cite
Save
Citations (110)
High positive sentinel node identification rate by EORTC melanoma group protocol: Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma
2006
European Journal of Cancer
A.C.J. van Akkooi
J.H.W. de Wilt
Cornelis Verhoef
Wilfried J. Graveland
A.N. van Geel
M. Kliffen
A.M.M. Eggermont
Show All
Source
Cite
Save
Citations (99)
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features
2003
Cancer
Martin J. van den Bent
Leendert Looijenga
K. Langenberg
Winand N.M. Dinjens
Wilfried J. Graveland
Ludo Uytdewilligen
Peter A. E. Sillevis Smitt
Robert B. Jenkins
Johan M. Kros
Show All
Source
Cite
Save
Citations (184)
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
2003
British Journal of Cancer
F.E. de Jongh
R N van Veen
S J Veltman
R. de Wit
M.E.L. van der Burg
M. J. van den Bent
A. S. T. Planting
Wilfried J. Graveland
G. Stoter
Jaap Verweij
Show All
Source
Cite
Save
Citations (183)
1